Compare FTV & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTV | BAX |
|---|---|---|
| Founded | 2015 | 1931 |
| Country | United States | United States |
| Employees | 18000 | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 13.9B |
| IPO Year | 2015 | 1994 |
| Metric | FTV | BAX |
|---|---|---|
| Price | $60.36 | $25.33 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 14 |
| Target Price | ★ $62.79 | $27.92 |
| AVG Volume (30 Days) | 1.8M | ★ 5.8M |
| Earning Date | 10-28-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.47% | 0.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.44 | 0.21 |
| Revenue | $6,452,700,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $5.08 | $3.33 |
| Revenue Next Year | $3.82 | $2.13 |
| P/E Ratio | $136.34 | ★ $121.83 |
| Revenue Growth | ★ 12.10 | 5.72 |
| 52 Week Low | $48.98 | $15.73 |
| 52 Week High | $64.56 | $30.00 |
| Indicator | FTV | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 57.41 |
| Support Level | $57.97 | $21.28 |
| Resistance Level | $60.79 | $25.99 |
| Average True Range (ATR) | 1.18 | 0.72 |
| MACD | 0.40 | 0.13 |
| Stochastic Oscillator | 90.88 | 75.45 |
Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.